| Ileal brake: a sensible food target for appetite control. A review PWJ Maljaars, HPF Peters, DJ Mela, AAM Masclee Physiology & behavior 95 (3), 271-281, 2008 | 498 | 2008 |
| Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial MJ de Jong, AE van der Meulen-de, MJ Romberg-Camps, MC Becx, ... The Lancet 390 (10098), 959-968, 2017 | 335 | 2017 |
| Effect of fat saturation on satiety, hormone release, and food intake J Maljaars, EA Romeyn, E Haddeman, HPF Peters, AAM Masclee The American journal of clinical nutrition 89 (4), 1019-1024, 2009 | 164 | 2009 |
| The gastrointestinal tract: neuroendocrine regulation of satiety and food intake J Maljaars, HPF Peters, AM Masclee Alimentary pharmacology & therapeutics 26, 241-250, 2007 | 131 | 2007 |
| Long-term evaluation of allogeneic bone marrow-derived mesenchymal stromal cell therapy for Crohn’s disease perianal fistulas MC Barnhoorn, MNJM Wasser, H Roelofs, PWJ Maljaars, I Molendijk, ... Journal of Crohn's and Colitis 14 (1), 64-70, 2020 | 111 | 2020 |
| Systematic review with meta‐analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation IC Steenstraten, K Sebib Korkmaz, PJ Trivedi, A Inderson, B van Hoek, ... Alimentary pharmacology & therapeutics 49 (6), 636-643, 2019 | 98 | 2019 |
| Effect of ileal fat perfusion on satiety and hormone release in healthy volunteers PWJ Maljaars, T Symersky, BC Kee, E Haddeman, HPF Peters, ... International journal of obesity 32 (11), 1633-1639, 2008 | 97 | 2008 |
| Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry VBC Biemans, JAM Sleutjes, AC de Vries, AGL Bodelier, G Dijkstra, ... Alimentary pharmacology & therapeutics 51 (9), 880-888, 2020 | 80 | 2020 |
| Influence of combination therapy with immune modulators on anti-TNF trough levels and antibodies in patients with IBD T van Schaik, JPW Maljaars, RK Roopram, MH Verwey, N Ipenburg, ... Inflammatory Bowel Diseases 20 (12), 2292-2298, 2014 | 73 | 2014 |
| The effect of lipid droplet size on satiety and peptide secretion is intestinal site-specific PWJ Maljaars, RJP van der Wal, T Wiersma, HPF Peters, E Haddeman, ... Clinical Nutrition 31 (4), 535-542, 2012 | 65 | 2012 |
| Length and site of the small intestine exposed to fat influences hunger and food intake PWJ Maljaars, HPF Peters, A Kodde, M Geraedts, FJ Troost, E Haddeman, ... British Journal of Nutrition 106 (10), 1609, 2011 | 57 | 2011 |
| Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease LM Spekhorst, F Imhann, EAM Festen, AA Van Bodegraven, NKH de Boer, ... BMJ open 7 (11), e016695, 2017 | 52 | 2017 |
| Towards a food pharmacy: immunologic modulation through diet I Molendijk, S van der Marel, PWJ Maljaars Nutrients 11 (6), 1239, 2019 | 49 | 2019 |
| Novel perceived stress and life events precede flares of inflammatory bowel disease: a prospective 12-month follow-up study DSJ Wintjens, MJ de Jong, AE van der Meulen-de Jong, ... Journal of Crohn's and Colitis 13 (4), 410-416, 2019 | 46 | 2019 |
| Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐and ustekinumab‐treated patients with inflammatory bowel disease—a prospective … VER Asscher, VBC Biemans, MJ Pierik, G Dijkstra, M Löwenberg, ... Alimentary pharmacology & therapeutics 52 (8), 1366-1376, 2020 | 43 | 2020 |
| Ustekinuma b for Crohn’s disease: two-year results of the Initiative on Crohn and Colitis (ICC) Registry, a nationwide prospective observational cohort study T Straatmijer, VBC Biemans, F Hoentjen, NKH De Boer, AGL Bodelier, ... Journal of Crohn's and Colitis 15 (11), 1920-1930, 2021 | 37 | 2021 |
| Safety of anti-TNF treatment in liver transplant recipients: a systematic review and meta-analysis MJ Westerouen van Meeteren, B Hayee, A Inderson, AE Van der Meulen, ... Journal of Crohn's and Colitis 11 (9), 1146-1151, 2017 | 35 | 2017 |
| Intragastric layering of lipids delays lipid absorption and increases plasma CCK but has minor effects on gastric emptying and appetite M Foltz, J Maljaars, EAH Schuring, RJP van der Wal, T Boer, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 296 (5 …, 2009 | 35 | 2009 |
| Superior effectiveness of tofacitinib compared to vedolizumab in anti-TNF-experienced ulcerative colitis patients: a nationwide Dutch registry study T Straatmijer, VBC Biemans, M Visschedijk, F Hoentjen, A de Vries, ... Clinical Gastroenterology and Hepatology 21 (1), 182-191. e2, 2023 | 31 | 2023 |
| Real‐world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases A Volkers, T Straatmijer, M Duijvestein, A Sales, A Levran, F van Schaik, ... Alimentary pharmacology & therapeutics 56 (6), 1044-1054, 2022 | 31 | 2022 |
David MelaIndependent nutrition scientistDirección de correo verificada de djmela.eu
